These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2293477)

  • 21. Newborn screening for sickle cell disease: effect on mortality.
    Vichinsky E; Hurst D; Earles A; Kleman K; Lubin B
    Pediatrics; 1988 Jun; 81(6):749-55. PubMed ID: 3368274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening checks newborns for galactosemia, hemoglobinopathy.
    J Okla State Med Assoc; 1991 Mar; 84(3):124-5. PubMed ID: 2030463
    [No Abstract]   [Full Text] [Related]  

  • 23. Neonatal haemoglobinopathy screening in Belgium.
    Gulbis B; Cotton F; Ferster A; Ketelslegers O; Dresse MF; Rongé-Collard E; Minon JM; Lé PQ; Vertongen F
    J Clin Pathol; 2009 Jan; 62(1):49-52. PubMed ID: 19103861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update: newborn screening for sickle cell disease--California, Illinois, and New York, 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Aug; 49(32):729-31. PubMed ID: 11411826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newborn screening for sickle cell disease and other hemoglobinopathies. Newborn screening in New York City.
    Grover R
    Pediatrics; 1989 May; 83(5 Pt 2):819-22. PubMed ID: 2717308
    [No Abstract]   [Full Text] [Related]  

  • 26. Sickle cell disease: screening and management in newborns and infants. Agency for Health Care Policy and Research.
    Smith JA; Kinney TR
    Am Fam Physician; 1993 Jul; 48(1):95-102. PubMed ID: 8322648
    [No Abstract]   [Full Text] [Related]  

  • 27. Application of molecular genetics in public health: improved follow-up in a neonatal hemoglobinopathy screening program.
    Zhang YH; McCabe LL; Wilborn M; Therrell BL; McCabe ER
    Biochem Med Metab Biol; 1994 Jun; 52(1):27-35. PubMed ID: 7522490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Tennessee Newborn Hemoglobinopathy Screening Program.
    Erickson S; Smith JC
    J Tenn Med Assoc; 1987 Apr; 80(4):223-4. PubMed ID: 3586637
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neonatal detection of sickle cell disease].
    Bardakdjian-Michau J
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S61-4. PubMed ID: 12592166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus conference. Newborn screening for sickle cell disease and other hemoglobinopathies.
    JAMA; 1987 Sep; 258(9):1205-9. PubMed ID: 3626004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saudi newborn screening: a national public health program: needs, costs, and challenges.
    Al-Awamy BH
    Saudi Med J; 2008 Mar; 29(3):470; author reply 470. PubMed ID: 18327387
    [No Abstract]   [Full Text] [Related]  

  • 32. Is universal neonatal hemoglobinopathy screening cost-effective?
    Bergman AB
    Arch Pediatr Adolesc Med; 1995 Apr; 149(4):466-7. PubMed ID: 7704180
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sickle cell disease in heel injection screening. II].
    Vansenne F; de Borgie CA; Bouva MJ; Legdeur MA; van Zwieten R; Petrij F; Peters M
    Ned Tijdschr Geneeskd; 2009 May; 153(18):858-61. PubMed ID: 19475864
    [No Abstract]   [Full Text] [Related]  

  • 34. [Neonatal diagnosis of hemoglobinopathies].
    Galactéros F
    Rev Prat; 1992 Oct; 42(15):1893-5. PubMed ID: 1485082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sickle cell disease neonatal screening. First evaluation].
    Mbodj M; Ndoye O; Diarra M; Mbaye BN; Sow Toure H; Diouf L; Gassama Seck S; Dhondt JL; Farriaux JP
    Dakar Med; 2003; 48(3):202-5. PubMed ID: 15776632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn screening for hemoglobinopathies in California.
    Michlitsch J; Azimi M; Hoppe C; Walters MC; Lubin B; Lorey F; Vichinsky E
    Pediatr Blood Cancer; 2009 Apr; 52(4):486-90. PubMed ID: 19061217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal screening for sickle cell disorders in Ouagadougou, Burkina Faso: a pilot study.
    Kafando E; Sawadogo M; Cotton F; Vertongen F; Gulbis B
    J Med Screen; 2005; 12(3):112-4. PubMed ID: 16156939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune].
    Schulpen TW; van der Lee JH; van der Most van Spijk MW; Beemer FA
    Ned Tijdschr Geneeskd; 1998 May; 142(18):1019-22. PubMed ID: 9623203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newborn screening for sickle cell disease and other hemoglobinopathies. Perspective from the National Association for Sickle Cell Disease.
    Whitten CF
    Pediatrics; 1989 May; 83(5 Pt 2):906-7. PubMed ID: 2717328
    [No Abstract]   [Full Text] [Related]  

  • 40. [Sickle cell disease: exotic disease or a Belgian public health problem?].
    Gulbis B; Ferster A; Kentos A; N'Gay Munungi D; Cotton F; Rongé E; Dresse MF; Bradstreet C; Cochaux P; Vertongen F
    Rev Med Brux; 2005 Sep; 26(4):S309-13. PubMed ID: 16240879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.